regpara tablets 25 mg
kyowa kirin asia pacific pte. ltd. - cinacalcet hydrochloride 27.55 mg eqv. cinacalcet - tablet, film coated - 25 mg - cinacalcet hydrochloride 27.55 mg eqv. cinacalcet 25 mg
parareg
dompé biotec s.p.a. - cinacalcet - hypercalcemia; parathyroid neoplasms; hyperparathyroidism - calcium homeostasis - treatment of secondary hyperparathyroidism (hpt) in patients with end-stage renal disease (esrd) on maintenance dialysis therapy.mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate (see section 5.1).reduction of hypercalcaemia in patients with:-parathyroid carcinoma.- primary hpt for whom parathyroidectomy would be indicated on the basis of serum calciumlevels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.
cinacalcet accord
accord healthcare limited - cinacalcet - film coated tablet - 30 milligram - cinacalcet
cinacalcet accord
accord healthcare limited - cinacalcet - film coated tablet - 60 milligram - cinacalcet
cinacalcet accord
accord healthcare limited - cinacalcet - film coated tablet - 90 milligram - cinacalcet
cinacalcet apotex
apotex europe b.v. - cinacalcet hydrochloride - film coated tablet - 30 milligram - cinacalcet
cinacalcet apotex
apotex europe b.v. - cinacalcet hydrochloride - film coated tablet - 60 milligram - cinacalcet
cinacalcet apotex
apotex europe b.v. - cinacalcet hydrochloride - film coated tablet - 90 milligram - cinacalcet
mimpara 30mg tablets
amgen ltd - cinacalcet hydrochloride - tablet - 30mg
mimpara 60mg tablets
amgen ltd - cinacalcet hydrochloride - tablet - 60mg